Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
by on Wednesday, May 16th, 2012 | No Comments
Conditions: Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer
Interventions: Drug: pazopanib hydrochloride; Other: laboratory biomarker analysis; Procedure: dynamic contrast-enhanced magnetic resonance imaging; Other: pharmacogenomic studies
Sponsors: University of Chicago; University of Chicago; National Cancer Institute (NCI)
Not yet recruiting – verified May 2012
See the original post here: Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer